HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

NARB Panel Finds Philosophy's Study Reliable For Time In A Bottle Claims

This article was originally published in The Rose Sheet

Executive Summary

The National Advertising Review Board's ruling on Coty/Philosophy's claims promoting the Time in a Bottle serum is considerably more favorable than the National Advertising Division's initial decision last year. Notably, the appellate body finds the advertiser's key clinical study reliable to support modified versions of statements NAD said should be discontinued, including a "two years younger" anti-aging claim.

You may also be interested in...



Philosophy To Defend Time in a Bottle Claims With NARB Appeal

NAD recommends discontinuation of numerous claims, many on product packaging, for the Coty brand’s Time in a Bottle Age-Defying Serum, citing flaws in the advertiser’s six-month, blinded clinical study. Philosophy will appeal to the National Advertising Review Board, arguing that “left uncorrected, the NAD’s decision would … disincentivize manufacturers from conducting similar comprehensive studies.”

FDA’s Cannabidiol Crackdown: What Do Warning Letters Say About CBD In Cosmetics?

Cannabidiol (CBD) represents an intriguing opportunity for cosmetics, without the statutory obstacles faced by food and dietary supplement companies. Cosmetics marketers are taking advantage, but the FDA’s recent warning letter blitz is a reminder that CBD-infused beauty products are bound by the same rules that apply to other cosmetics.

US House Cosmetics Hearing: Preemption, FDA Ingredient Review Could Be Regulatory Reform Snags

Federal preemption of state and local requirements that differ from federal mandates came up repeatedly at the House Energy & Commerce Health Subcommittee’s 4 December cosmetics hearing. Meanwhile, both NGO and industry stakeholders generally support FDA review of cosmetic ingredients, but the details of such a framework likely will be contentious as work progresses.

Related Companies

UsernamePublicRestriction

Register

RS019505

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel